These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32295518)

  • 1. Reduced serum levels of pro-inflammatory chemokines in fragile X syndrome.
    Van Dijck A; Barbosa S; Bermudez-Martin P; Khalfallah O; Gilet C; Martinuzzi E; Elinck E; Kooy RF; Glaichenhaus N; Davidovic L
    BMC Neurol; 2020 Apr; 20(1):138. PubMed ID: 32295518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cytokine profiles in Fragile X subjects: is there a role for cytokines in the pathogenesis?
    Ashwood P; Nguyen DV; Hessl D; Hagerman RJ; Tassone F
    Brain Behav Immun; 2010 Aug; 24(6):898-902. PubMed ID: 20102735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new strategy to uncover fragile X proteomic biomarkers using the nascent proteome of peripheral blood mononuclear cells (PBMCs).
    Dionne O; Corbin F
    Sci Rep; 2021 Jul; 11(1):15148. PubMed ID: 34312401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory profiles in plasma and cerebrospinal fluid of patients with neurosarcoidosis.
    Byg KE; Illes Z; Sejbaek T; Lambertsen KL; Ellingsen T; Nielsen HH
    J Neuroimmunol; 2022 Jun; 367():577849. PubMed ID: 35366560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol levels in fragile X syndrome.
    Berry-Kravis E; Levin R; Shah H; Mathur S; Darnell JC; Ouyang B
    Am J Med Genet A; 2015 Feb; 167A(2):379-84. PubMed ID: 25424470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelets as a surrogate disease model of neurodevelopmental disorders: Insights from Fragile X Syndrome.
    Pellerin D; Lortie A; Corbin F
    Platelets; 2018 Mar; 29(2):113-124. PubMed ID: 28660769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Levels of Leptin and Adiponectin in Fragile X Syndrome.
    Lisik MZ; Gutmajster E; Sieroń AL
    Neuroimmunomodulation; 2016; 23(4):239-243. PubMed ID: 27902989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of protein synthesis are reduced in peripheral blood mononuclear cells (PBMCs) from fragile X individuals.
    Dionne O; Lortie A; Gagnon F; Corbin F
    PLoS One; 2021; 16(5):e0251367. PubMed ID: 33974659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights of altered lipid profile in Fragile X Syndrome.
    Çaku A; Seidah NG; Lortie A; Gagné N; Perron P; Dubé J; Corbin F
    PLoS One; 2017; 12(3):e0174301. PubMed ID: 28334053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of visual and auditory evoked potentials in fragile X syndrome.
    Knoth IS; Vannasing P; Major P; Michaud JL; Lippé S
    Int J Dev Neurosci; 2014 Aug; 36():90-7. PubMed ID: 24875778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans.
    Won J; Jin Y; Choi J; Park S; Lee TH; Lee SR; Chang KT; Hong Y
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-neuronal antibodies in patients with fragile X syndrome: is there a role of autoimmunity in its pathogenesis?
    Lisik MZ; Gutmajster E; Sieroń AL
    Neurodegener Dis; 2015; 15(1):45-9. PubMed ID: 25500855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragile X syndrome: a review of clinical and molecular diagnoses.
    Ciaccio C; Fontana L; Milani D; Tabano S; Miozzo M; Esposito S
    Ital J Pediatr; 2017 Apr; 43(1):39. PubMed ID: 28420439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine microRNA Profiling Displays miR-125a Dysregulation in Children with Fragile X Syndrome.
    Putkonen N; Laiho A; Ethell D; Pursiheimo J; Anttonen AK; Pitkonen J; Gentile AM; de Diego-Otero Y; Castrén ML
    Cells; 2020 Jan; 9(2):. PubMed ID: 31991700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokines in Kawasaki disease: measurement of CCL2, CCL22 and CXCL10.
    Shikishima Y; Saeki T; Matsuura N
    Asian Pac J Allergy Immunol; 2003 Sep; 21(3):139-43. PubMed ID: 15032397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome.
    Brasa S; Mueller A; Jacquemont S; Hahne F; Rozenberg I; Peters T; He Y; McCormack C; Gasparini F; Chibout SD; Grenet O; Moggs J; Gomez-Mancilla B; Terranova R
    Clin Epigenetics; 2016; 8():15. PubMed ID: 26855684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensory Processing Phenotypes in Fragile X Syndrome.
    Rais M; Binder DK; Razak KA; Ethell IM
    ASN Neuro; 2018; 10():1759091418801092. PubMed ID: 30231625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Brain Network Segregation in Fragile X Syndrome Revealed by Structural Connectomics.
    Bruno JL; Hosseini SMH; Saggar M; Quintin EM; Raman MM; Reiss AL
    Cereb Cortex; 2017 Mar; 27(3):2249-2259. PubMed ID: 27009247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating social preference and social anxiety phenotypes in fragile X syndrome using an eye gaze analysis: a pilot study.
    Hong MP; Eckert EM; Pedapati EV; Shaffer RC; Dominick KC; Wink LK; Sweeney JA; Erickson CA
    J Neurodev Disord; 2019 Jan; 11(1):1. PubMed ID: 30665413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.